HIV AIDSInfo Center
Why Early HIV Treatment Matters
There may be some good news for HIV patients — starting medication immediately after diagnosis may help keep patients healthy longer.
Anti-Herpes Rx Did Double Duty
Genital herpes and HIV are similar in that both are sexually transmitted viruses — and now it looks as though they might also respond to the same medication.
HIV May Hamper Hearing
Hearing loss may not always be the result of too much loud music in your younger days. If you're HIV-positive, hearing loss could be a product of your condition.
Early Therapy May Keep HIV Patients Healthy
They say timing is everything — and that may apply to HIV treatment. Starting antiretroviral therapy early may keep HIV patients healthy.
On World AIDS Day, Organizers Focus on Raising Awareness
Today is World AIDS Day, a special day to raise awareness about HIV and AIDS and to bring people together in the fight against the epidemic. This year's theme is "Focus, Partner, Achieve: An AIDS-Free Generation."
HIV Patients Not Receiving Regular Care
With new medications and treatments, HIV therapy has dramatically improved over the past two decades. Many with the virus, however, may not be getting proper treatment.
New HIV Care Includes Medical and Behavioral Treatment
Human immunodeficiency virus (HIV) is a sexually transmitted disease that can be deadly. HIV infection often goes undetected in patients who do not seek care. However, new research says that there may be new ways to use HIV care so that the virus becomes manageable.
Dual Therapy May Control Hepatitis C in HIV Patients
For patients with human immunodeficiency virus (HIV), hepatitis C (HCV) can also be a problem. A new combination of medications, however, may effectively treat HCV in those with HIV.
HIV Diagnosis Rate Dropped
HIV has been a national concern for years, but new data suggest that serious progress has been made.
Some Minorities With HIV, AIDS Were Least Likely to Take Rx
According to new research, African-American and Latino people with HIV or AIDS were the least likely to take medication that could extend their lives. Researchers may now have some of the answers as to why.